Articles

Rapid & Robust Preclinical & Clinical Development of CAR T-Cell Therapies

This case study distinguishes how Covance helped the sponsor identify lead assets, navigate through IND-submission and conduct Phase I/II dosing studies in an accelerated timeframe.